Masataka Nonaka
Präsident bei Tauns Laboratories, Inc.
Vermögen: 76 Mio $ am 31.05.2024
Profil
Masataka Nonaka is currently the Representative Director at TAUNS Holdings Co., Ltd.
and the President & Representative Director at TAUNS Laboratories, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Tauns Laboratories, Inc.
 Tauns Laboratories, Inc. Medical SpecialtiesHealth Technology TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan. 28,95% | 20.06.2024 | 28 947 600 ( 28,95% ) | 76 Mio $ | 31.05.2024 |
Aktive Positionen von Masataka Nonaka
| Unternehmen | Position | Beginn |
|---|---|---|
TAUNS Holdings Co., Ltd.
 TAUNS Holdings Co., Ltd. Financial ConglomeratesFinance TAUNS Holdings Co., Ltd. engages in the management and operation of its group of companies that conduct research and development, manufacturing, and sales of in-vitro diagnostic drugs. The company was founded on April 14, 2016 and is headquartered in Izunokuni, Japan. | Direktor/Vorstandsmitglied | - |
Tauns Laboratories, Inc.
Tauns Laboratories, Inc. Medical SpecialtiesHealth Technology TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan. | Präsident | 01.09.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TAUNS Holdings Co., Ltd.
TAUNS Holdings Co., Ltd. Financial ConglomeratesFinance TAUNS Holdings Co., Ltd. engages in the management and operation of its group of companies that conduct research and development, manufacturing, and sales of in-vitro diagnostic drugs. The company was founded on April 14, 2016 and is headquartered in Izunokuni, Japan. | Finance |
